HIGHLIGHTS
- who: F. B. Mensink from the Turkey University of Milan, Italy have published the paper: Pharmaco-invasive therapy: Early implementation of statins and proprotein convertase subtilisin/kexin type 9 inhibitors after acute coronary syndrome, in the Journal: (JOURNAL)
- what: In this review the authors discuss how elevated serum LDL-C and inflammation cause recurrent cardiovascular events by negatively influencing non-culprit plaque size and composition in patients post-ACS.
- future: Contemporary and future studies with proprotein convertase subtilisin/kexin type 9 inhibitors muscle cells and endothelial cells promoting endothelial permeability and fibrous cap . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.